Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Accumulated Expenses (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Other Accumulated Expenses for 4 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 172.71% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 172.71% year-over-year, with the annual reading at $1.6 million for FY2025, 172.71% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $1.6 million at Orchestra BioMed Holdings, down from $1.7 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.9 million in Q4 2022, with the low at $379000.0 in Q2 2024.
  • Average Other Accumulated Expenses over 4 years is $1.1 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses tumbled 61.21% in 2024, then surged 172.71% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $1.9 million in 2022, then plummeted by 43.0% to $1.1 million in 2023, then crashed by 46.34% to $579000.0 in 2024, then soared by 172.71% to $1.6 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $1.6 million, $1.7 million, and $879000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.